Tyra Biosciences (TYRA) Current Leases (2020 - 2026)
Tyra Biosciences (TYRA) posted Current Leases of $488000.0 for Q1 2026, up 3.39% on a QoQ basis from $472000.0 in Q4 2025, and up 14.55% year-over-year from $426000.0 in Q1 2025.
Tyra Biosciences (TYRA) Current Leases (2020 - 2026) Analysis & Trends
Tyra Biosciences' Current Leases history runs 7 years deep, the most recent figure standing at $488000.0 for Q1 2026.
- Quarterly Current Leases rose 14.55% year-over-year to $488000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $488000.0 (up 14.55% YoY) and the FY2025 annual result came in at $472000.0, up 14.56% from the prior year.
- Current Leases was $488000.0 for Q1 2026 at Tyra Biosciences, up from $472000.0 in the prior quarter.
- Across five years, Current Leases topped out at $488000.0 in Q1 2026 and bottomed at $119000.0 in Q1 2022.
- A 5-year average of $298294.1 and a median of $370000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 30.69% — and 2024, when it soared 168.92%.
- Tyra Biosciences' Current Leases stood at $140000.0 in 2022, then jumped by 100.0% to $280000.0 in 2023, then jumped by 47.14% to $412000.0 in 2024, then grew by 14.56% to $472000.0 in 2025, then advanced by 3.39% to $488000.0 in 2026.
- Business Quant data shows TYRA's Current Leases at $488000.0 in Q1 2026, $472000.0 in Q4 2025, and $456000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | 488,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 488,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 441,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 398,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Mar 31, 2024 | 370,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 123,000.00 |
| Mar 31, 2022 | 119,000.00 |
| Dec 31, 2021 | 202,000.00 |
| Sep 30, 2021 | 135,000.00 |
| Dec 31, 2020 | 142,000.00 |